Evidence map›Paper›PMID 39141588›Full record

SynthesisInternational journal of language & communication disorders

Parent-reported outcome measures evaluating communication in individuals with rare neurodevelopmental disorders: A systematic review.

Jacinta M Saldaris, Jeremiah Ayalde, Samali Kankanange, Jessica Keeley, Helen Leonard, Peter Jacoby, Eric D Marsh, Tim A Benke, Scott T Demarest, Jenny Downs

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of language & communication disorders. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jacinta M SaldarisTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0000-0003-4638-6589
Jeremiah AyaldeTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0000-0002-3560-3106
Samali KankanangeTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0009-0001-9966-0214
Jessica KeeleyTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0000-0001-9613-4713
Helen LeonardTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0000-0001-6405-5834
Peter JacobyTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0000-0001-5092-7697
Eric D MarshChildren's Hospital of Philadelphia, Division of Child Neurology, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-3264-0902
Tim A BenkeChildren's Hospital Colorado, Neurology and Pharmacology, Aurora, Colorado, USA.ORCID 0000-0002-6969-5061
Scott T DemarestChildren's Hospital Colorado, Neurology and Pharmacology, Aurora, Colorado, USA.ORCID 0000-0002-4544-3724
Jenny DownsTelethon Kids Institute, Nedlands, Western Australia, Australia.ORCID 0000-0001-7358-9037

Funding

Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency DisorderU01NS114312 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BENKE, TIMOTHY A, DOWNS, JENNY · 2021 to 2025
$4.7M
International Foundation for CDKL5 ResearchNINDS NIH HHS U01 NS114312Ponzio Family Chair in Neurology ResearchStan Perron Charitable Foundation
6 · The paper itself

Abstract

backgroundCommunication impairments are a leading concern for parent caregivers of individuals with rare neurodevelopmental disorders (RNDDs). Clinical trials of disease modifying therapies require valid and responsive outcome measures that are relevant to individuals with RNDDs. Identifying and evaluating current psychometric properties for communication measures is a critical step towards the selection and use of appropriate instruments.

aimsThis systematic review offers (1) a description of parent-reported communication measures and (2) evidence for their psychometric properties, in RNDDs.

methodsThe systematic review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42022334649). MEDLINE (Ovid), Embase, PsychINFO, Web of Science, CINAHL Plus, Cochrane Library, ClinicalTrials.gov, the Australian New Zealand Clinical Trials Registry were searched from inception to August 2023. Methodological assessment of quality was completed using the COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) checklist. Parent-reported measures used in observational studies and clinical trials were identified. Data on utility, reliability and validity for RNDDs were extracted. MAIN CONTRIBUTION: Sixteen parent-reported communication measures were used in RNDD research, the Vineland Adaptive Behavior Scales being most commonly used. Validation data in RNDDs were identified for six of these measures. Limitations related to sample size or the scope of psychometric testing.

conclusionsMany communication measures have been used for RNDDs but there are few data validating their use. Valid and reliable methods of measuring communication in persons with RNDDs is a priority for future high-quality clinical trials. WHAT THIS PAPER ADDS: What is already known on the subject Communication is a critical domain for families with a child with a rare neurodevelopmental disorder (RNDD). Validated outcome measures are essential for accurate evaluation and interpretation of responses to treatments in clinical trials. What this paper adds to existing knowledge We identified 16 parent-reported communication measures that have been used with RNDDs, but only six measures had validation data for at least one RNDD. High quality evidence is accumulating, with all validation studies in this review published between 2020 to 2023. Modifications of existing measures may be required to assess communication for RNDDs. What are the clinical implications of this work? This systematic review catalogues the available psychometric data for communication measures and indicates an ongoing need for new validation studies to ensure they are fit-for-purpose for upcoming clinical trials in RNDDs. This review will inform the selection of communication measures for clinical trials and research studies.

Indexed as

Neurodevelopmental DisordersParentsPsychometricsChildCommunicationCommunication DisordersHumansPatient Reported Outcome MeasuresRare DiseasesReproducibility of Resultsclinical trial readinesscommunicationparent‐reported outcome measurespsychometric propertiesrare neurodevelopmental disorders

Identifiers

PMID39141588
PMCPMC11649302

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.